Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Systemic Radioligand Therapy with Lu-177 Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer EDITORIAL COMMENT JOURNAL OF UROLOGY Iagaru, A. 2016; 196 (2): 390
View details for DOI 10.1016/j.juro.2016.02.2999
View details for Web of Science ID 000379266400036
View details for PubMedID 27207377